Total Payments
$488.21
2024 Payments
$199.40
Companies
16
Transactions
28
Medicare Patients
6,013
Medicare Billing
$327,648
Payment Breakdown by Category
Food & Beverage$488.21 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $488.21 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $94.01 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $74.99 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $74.49 | 5 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $34.33 | 2 | $0 (2024) |
| Exact Sciences Corporation | $30.82 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.86 | 1 | $0 (2024) |
| PFIZER INC. | $22.56 | 1 | $0 (2024) |
| Lundbeck LLC | $20.64 | 1 | $0 (2024) |
| Mylan Specialty L.P. | $19.52 | 1 | $0 (2023) |
| Lilly USA, LLC | $14.88 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $199.40 | 11 | Amgen Inc. ($94.01) |
| 2023 | $110.49 | 7 | GlaxoSmithKline, LLC. ($60.15) |
| 2022 | $102.30 | 3 | Merck Sharp & Dohme LLC ($74.99) |
| 2021 | $76.02 | 7 | Lilly USA, LLC ($14.88) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Inflammation | ||||||
| 10/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.64 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: DIABETES | ||||||
| 09/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Inflammation | ||||||
| 08/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Inflammation | ||||||
| 07/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Inflammation | ||||||
| 05/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Inflammation | ||||||
| 03/19/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: RESPIRATORY | ||||||
| 08/30/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/25/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Oncology | ||||||
| 04/27/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: RESPIRATORY | ||||||
| 04/12/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Oncology | ||||||
| 08/31/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: RESPIRATORY | ||||||
| 05/09/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $74.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/16/2022 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/12/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: UROLOGY | ||||||
| 08/03/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/26/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Diabetes | ||||||
| 05/20/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,061 | 1,891 | $148,552 | $56,321 |
| 2022 | 15 | 1,442 | 2,232 | $198,154 | $82,260 |
| 2021 | 14 | 1,743 | 2,293 | $230,771 | $100,613 |
| 2020 | 15 | 1,767 | 2,173 | $231,033 | $88,454 |
Total Patients
6,013
Total Services
8,589
Medicare Billing
$327,648
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 302 | 427 | $50,813 | $21,412 | 42.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 133 | 202 | $31,714 | $12,935 | 40.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 99 | 99 | $17,820 | $10,563 | 59.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 94 | 94 | $14,100 | $6,224 | 44.1% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 98 | 98 | $7,350 | $1,489 | 20.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 98 | 98 | $7,350 | $1,489 | 20.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 67 | 108 | $4,860 | $817.28 | 16.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,464 | $467.45 | 19.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 59 | 528 | $6,336 | $375.49 | 5.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 11 | 11 | $825.00 | $348.70 | 42.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 52 | 68 | $2,040 | $149.60 | 7.3% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 34 | 144 | $2,880 | $50.51 | 1.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 367 | 524 | $62,356 | $27,107 | 43.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 190 | 250 | $39,250 | $18,905 | 48.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 147 | 147 | $26,460 | $15,759 | 59.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 111 | 111 | $16,650 | $7,651 | 46.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 61 | 66 | $10,362 | $5,353 | 51.7% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 144 | 144 | $10,800 | $2,208 | 20.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 146 | 146 | $10,950 | $2,198 | 20.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 63 | 101 | $4,545 | $880.09 | 19.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 24 | 48 | $2,160 | $783.80 | 36.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $1,936 | $366.26 | 18.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 53 | 430 | $5,160 | $360.25 | 7.0% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 11 | 12 | $1,200 | $338.86 | 28.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 65 | 77 | $2,310 | $170.52 | 7.4% |
About Wildon Rouse
Wildon Rouse is a Physician Assistant healthcare provider based in La Grange, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003873845.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Wildon Rouse has received a total of $488.21 in payments from pharmaceutical and medical device companies, with $199.40 received in 2024. These payments were reported across 28 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($488.21).
As a Medicare-enrolled provider, Rouse has provided services to 6,013 Medicare beneficiaries, totaling 8,589 services with total Medicare billing of $327,648. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location La Grange, TX
- Active Since 04/26/2006
- Last Updated 12/04/2013
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1003873845
Products in Payments
- Otezla (Drug) $94.01
- VERQUVO (Drug) $74.99
- TRELEGY ELLIPTA (Drug) $74.49
- FARXIGA (Drug) $34.33
- Cologuard Collection Kit (Device) $30.82
- JARDIANCE (Drug) $27.86
- ELIQUIS (Drug) $22.56
- REXULTI (Drug) $20.64
- YUPELRI (Drug) $19.52
- TRULICITY (Drug) $14.88
- VRAYLAR (Drug) $14.61
- XARELTO (Drug) $13.04
- QSYMIA (Drug) $12.97
- ENTRESTO (Drug) $12.94
- MYRBETRIQ (Drug) $11.27
- Xofluza (Drug) $9.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in La Grange
Mrs. Chelsea Jecmenek, Pa, PA
Physician Assistant — Payments: $7,104
Physician Assistant $7,104
Ms. Kelsey York, Pa-C, PA-C
Physician Assistant — Payments: $1,564
Physician Assistant $1,564
Mrs. Hanna Pilat, Pa-C, PA-C
Physician Assistant — Payments: $1,210
Physician Assistant $1,210
Jennifer Emmel, Pa-C, PA-C
Physician Assistant — Payments: $878.54
Physician Assistant $878.54
Karen Fu
Physician Assistant — Payments: $232.95
Physician Assistant $232.95
Taylor Snyders, Pa-C, PA-C
Physician Assistant — Payments: $85.46
Physician Assistant $85.46